Third Harmonic Bio (Nasdaq: THRD) has announced its Board of Directors’ approval of a Plan of Liquidation and Dissolution, subject to stockholder approval at the Annual Meeting on June 5, 2025. The company plans to distribute remaining cash to stockholders and sell its assets, including the THB335 program.
The initial distribution is expected to be between $246.6 million and $255.4 million (approximately $5.13-$5.33 per share) in Q3 2025. The total distribution could reach between $246.6 million and $259.8 million ($5.13-$5.42 per share), not including potential proceeds from asset sales.
Following stockholder approval, the company intends to file a Certificate of Dissolution,…
